Unresectable Chordoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma (NCT05041127) | M.D. Anderson Cancer Center | 2022-05-27 |
| Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma (NCT03623854) | Jonsson Comprehensive Cancer Center | 2019-04-03 |
Track Unresectable Chordoma automatically
Every clearance here is in the API, with alerts when new ones post.